<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="11/03/2007" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1645452" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>1645452</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The <term sem="Cell_cultured" id="T1" lex="human_myelomonocytic_cell_line_U-937">human myelomonocytic cell line U-937</term> as a model for studying alterations in <term sem="Other" id="T2" lex="steroid-induced_monokine_gene_expression"><term sem="Lipid" id="A2">steroid</term>-induced <term sem="DNA_domain_or_region" id="A1">monokine gene</term> expression</term>: marked enhancement of <term sem="Other" id="T3" lex="lipopolysaccharide-stimulated_interleukin-1_beta_messenger_RNA_level"><term sem="RNA_molecule" id="T4" lex="lipopolysaccharide-stimulated_interleukin-1_beta_messenger_RNA"><term sem="Lipid" id="A5">lipopolysaccharide</term>-stimulated <term sem="RNA_molecule" id="A3"><term sem="Protein_molecule" id="T5" lex="interleukin-1_beta">interleukin-1 beta</term> messenger RNA</term></term> levels</term> by <term sem="Lipid" id="T6" lex="1,25-dihydroxyvitamin_D3">1,25-dihydroxyvitamin D3</term>.</sentence>
<event id="E1">
<type class="Gene_expression" />
<theme idref="A1" />
<clue>The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene <clueType>expression</clueType>: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="E1" />
<cause idref="A2" />
<clue>The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-<clueType>induced</clueType> monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3.</clue>
</event>
<event uncertainty="doubtful" id="E3">
<type class="Regulation" />
<theme idref="E2" />
<clue>The <clueLoc>human myelomonocytic cell line U-937</clueLoc> as a model for studying <clueType>alterations</clueType> in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3.</clue>
</event>
<event id="E4">
<type class="Transcription" />
<theme idref="A3" />
<clue>The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA <clueType>levels</clueType> by 1,25-dihydroxyvitamin D3.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="E4" />
<cause idref="A5" />
<clue>The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-<clueType>stimulated</clueType> interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="E5" />
<cause idref="T6" />
<clue>The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked <clueType>enhancement</clueType> <linkTheme>of</linkTheme> lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels <linkCause>by</linkCause> 1,25-dihydroxyvitamin D3.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The active metabolite of <term sem="Lipid" id="T7" lex="vitamin_D">vitamin D</term>, <term sem="Lipid" id="T8" lex="1,25-dihydroxyvitamin_D3">1,25-dihydroxyvitamin D3</term> [<term sem="Lipid" id="T9" lex="1,25-_(OH)2D3">1,25-(OH)2D3</term>], is a potent regulator of human <term sem="Cell_natural" id="A6">monocyte</term>/<term sem="Cell_natural" id="A7">macrophage</term> function in vitro.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="A6" />
<cause idref="T9" />
<clue>The active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], is a potent <clueType>regulator</clueType> <linkTheme>of</linkTheme> human monocyte/macrophage function in vitro.</clue>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="A7" />
<cause idref="T9" />
<clue>The active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], is a potent <clueType>regulator</clueType> <linkTheme>of</linkTheme> human monocyte/macrophage function in vitro.</clue>
</event>
<event id="E9">
<type class="Metabolism" />
<theme idref="T7" />
<theme idref="T9" />
<clue>The active <clueType>metabolite</clueType> <linkTheme>of</linkTheme> vitamin D, 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3], is a potent regulator of human monocyte/macrophage function in vitro.</clue>
</event>
<sentence id="S3">To establish a model for <term sem="Other" id="T10" lex="1,25-(OH)2D3_regulation"><term sem="Lipid" id="T11" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> regulation</term> of <term sem="Other" id="T12" lex="human_monocyte_monokine_synthesis">human monocyte <term sem="Protein_family_or_group" id="A8">monokine</term> synthesis</term>, three <term sem="Cell_cultured" id="T13" lex="human_cell_line">human cell lines</term> (<term sem="Cell_cultured" id="T14" lex="U-937">U-937</term>, <term sem="Cell_cultured" id="T15" lex="THP-1">THP-1</term>, and <term sem="Cell_cultured" id="T16" lex="HL-60">HL-60</term>) were examined for: 1) the presence of functional <term sem="Protein_molecule" id="A9"><term sem="Lipid" id="T17" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> receptors</term>; 2) the accumulation of <term sem="RNA_molecule" id="T18" lex="interleukin-1_beta_(IL-1_beta)_mRNA"><term sem="Protein_molecule" id="T19" lex="interleukin-1_beta">interleukin-1 beta</term> (<term sem="Protein_molecule" id="T20" lex="IL-1_beta">IL-1 beta</term>) mRNA</term> and <term sem="Protein_molecule" id="T21" lex="IL-1_beta_protein"><term sem="Protein_molecule" id="T22" lex="IL-1_beta">IL-1 beta</term> protein</term> in response to <term sem="Lipid" id="T23" lex="lipopolysaccharide">lipopolysaccharide</term> (<term sem="Lipid" id="T24" lex="LPS">LPS</term>); and 3) the regulation of this response by <term sem="Lipid" id="T25" lex="1,25-(OH)2D3">1,25-(OH)2D3</term>.</sentence>
<event id="E10">
<type class="Gene_expression" />
<theme idref="A8" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of <clueLoc>human monocyte</clueLoc> monokine <clueType>synthesis</clueType>, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E11">
<type class="Regulation" />
<theme idref="E10" />
<cause idref="T11" />
<clue>To establish a model for 1,25-(OH)2D3 <clueType>regulation</clueType> of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E300">
<type class="Gene_expression" />
<theme idref="A9" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (<clueLoc>U-937</clueLoc>, THP-1, and HL-60) were examined for: 1) the <clueType>presence</clueType> <linkTheme>of</linkTheme> functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E301">
<type class="Gene_expression" />
<theme idref="A9" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, <clueLoc>THP-1</clueLoc>, and HL-60) were examined for: 1) the <clueType>presence</clueType> <linkTheme>of</linkTheme> functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E302">
<type class="Gene_expression" />
<theme idref="A9" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, THP-1, and <clueLoc>HL-60</clueLoc>) were examined for: 1) the <clueType>presence</clueType> <linkTheme>of</linkTheme> functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E303">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (<clueLoc>U-937</clueLoc>, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E304">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, <clueLoc>THP-1</clueLoc>, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E305">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, THP-1, and <clueLoc>HL-60</clueLoc>) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E306">
<type class="Positive_regulation" />
<theme idref="T21" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (<clueLoc>U-937</clueLoc>, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E307">
<type class="Positive_regulation" />
<theme idref="T21" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, <clueLoc>THP-1</clueLoc>, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E308">
<type class="Positive_regulation" />
<theme idref="T21" />
<cause idref="T24" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three <clueLoc>human cell lines</clueLoc> (U-937, THP-1, and <clueLoc>HL-60</clueLoc>) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the <clueType>accumulation</clueType> <linkTheme>of</linkTheme> interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein <linkCause>in response to</linkCause> lipopolysaccharide (LPS); and 3) the regulation of this response by 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E309">
<type class="Regulation" />
<theme idref="E303" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E310">
<type class="Regulation" />
<theme idref="E304" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E311">
<type class="Regulation" />
<theme idref="E305" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E312">
<type class="Regulation" />
<theme idref="E306" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E313">
<type class="Regulation" />
<theme idref="E307" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<event uncertainty="doubtful" id="E314">
<type class="Regulation" />
<theme idref="E308" />
<cause idref="T25" />
<clue>To establish a model for 1,25-(OH)2D3 regulation of human monocyte monokine synthesis, three human cell lines (U-937, THP-1, and HL-60) were examined for: 1) the presence of functional 1,25-(OH)2D3 receptors; 2) the accumulation of interleukin-1 beta (IL-1 beta) mRNA and IL-1 beta protein in response to lipopolysaccharide (LPS); and 3) the <clueType>regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>this response</corefTheme> <linkCause>by</linkCause> 1,25-(OH)2D3.</clue>
</event>
<sentence id="S4">All three cell lines expressed <term sem="Protein_molecule" id="A10"><term sem="Lipid" id="T26" lex="vitamin_D">vitamin D</term> receptor</term> and had increased levels of <term sem="RNA_molecule" id="T27" lex="IL-1_beta_mRNA"><term sem="Protein_molecule" id="T28" lex="IL-1_beta">IL-1 beta</term> mRNA</term> in response to <term sem="Lipid" id="T29" lex="LPS">LPS</term>.</sentence>
<event id="E17">
<type class="Gene_expression" />
<theme idref="A10" />
<clue>All three cell lines <clueType>expressed</clueType> vitamin D receptor and had increased levels of IL-1 beta mRNA in response to LPS.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="T27" />
<cause idref="T29" />
<clue>All three cell lines expressed vitamin D receptor and had <clueType>increased</clueType> levels <linkTheme>of</linkTheme> IL-1 beta mRNA <linkCause>in response to</linkCause> LPS.</clue>
</event>
<sentence id="S5">Preincubation of cells with <term sem="Lipid" id="T30" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> augmented <term sem="Other" id="T31" lex="IL-1_beta_mRNA_level"><term sem="RNA_molecule" id="T32" lex="IL-1_beta_mRNA"><term sem="Protein_molecule" id="T33" lex="IL-1_beta">IL-1 beta</term> mRNA</term> levels</term> only in <term sem="Cell_cultured" id="T34" lex="U-937">U-937</term> and <term sem="Cell_cultured" id="T35" lex="HL-60">HL-60</term> cells.</sentence>
<event id="E19">
<type class="Artificial_process" />
<theme idref="T30" />
<theme idref="T14" />
<clue><clueType>Preincubation</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T14">cells</corefTheme> <linkTheme>with</linkTheme> 1,25-(OH)2D3 augmented IL-1 beta mRNA levels only in U-937 and HL-60 cells.</clue>
</event>
<event id="E20">
<type class="Artificial_process" />
<theme idref="T30" />
<theme idref="T15" />
<clue><clueType>Preincubation</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T15">cells</corefTheme> <linkTheme>with</linkTheme> 1,25-(OH)2D3 augmented IL-1 beta mRNA levels only in U-937 and HL-60 cells.</clue>
</event>
<event id="E21">
<type class="Artificial_process" />
<theme idref="T30" />
<theme idref="T16" />
<clue><clueType>Preincubation</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T16">cells</corefTheme> <linkTheme>with</linkTheme> 1,25-(OH)2D3 augmented IL-1 beta mRNA levels only in U-937 and HL-60 cells.</clue>
</event>
<event id="E22">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="E19" />
<clue>Preincubation of cells with 1,25-(OH)2D3 <clueType>augmented</clueType> IL-1 beta mRNA levels only <clueLoc>in U-937</clueLoc> and HL-60 <clueLoc>cells</clueLoc>.</clue>
</event>
<event id="E23">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="E21" />
<clue>Preincubation of cells with 1,25-(OH)2D3 <clueType>augmented</clueType> IL-1 beta mRNA levels only <clueLoc>in</clueLoc> U-937 and <clueLoc>HL-60 cells</clueLoc>.</clue>
</event>
<sentence id="S6">From these data, and taking into consideration their state of differentiation and relative ease of culture, <term sem="Cell_cultured" id="T36" lex="U-937">U-937</term> was chosen over <term sem="Cell_cultured" id="T37" lex="HL-60">HL-60</term> and <term sem="Cell_cultured" id="T38" lex="THP-1">THP-1</term> as the cell line we further characterized.</sentence>
<sentence id="S7">In <term sem="Cell_cultured" id="T39" lex="U-937_cell"><term sem="Cell_cultured" id="T40" lex="U-937">U-937</term> cells</term>, optimum time and dose of pretreatment with <term sem="Lipid" id="T41" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> were determined to be 12-24 h at a receptor saturating concentration of <term sem="Lipid" id="T42" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> (10 nM).</sentence>
<event id="E24">
<type class="Artificial_process" />
<theme idref="T39" />
<theme idref="T41" />
<clue>In U-937 cells, optimum time and dose of <clueType>pretreatment</clueType> <linkTheme>with</linkTheme> 1,25-(OH)2D3 were determined to be <clueTime>12-24 h</clueTime> at a receptor saturating concentration of 1,25-(OH)2D3 (10 nM).</clue>
</event>
<sentence id="S8">Preincubation of cells with <term sem="Lipid" id="T43" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> had no effect on the time course of <term sem="RNA_molecule" id="T44" lex="IL-1_beta_mRNA"><term sem="Protein_molecule" id="T45" lex="IL-1_beta">IL-1 beta</term> mRNA</term> appearance in response to <term sem="Lipid" id="T46" lex="LPS">LPS</term>.</sentence>
<event id="E25">
<type class="Artificial_process" />
<theme idref="T43" />
<theme idref="T39" />
<clue><clueType>Preincubation</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T39">cells</corefTheme> <linkTheme>with</linkTheme> 1,25-(OH)2D3 had no effect on the time course of IL-1 beta mRNA appearance in response to LPS.</clue>
</event>
<event id="E26">
<type class="Transcription" />
<theme idref="T44" />
<clue>Preincubation of cells with 1,25-(OH)2D3 had no effect on the time course of IL-1 beta mRNA <clueType>appearance</clueType> in response to LPS.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="E26" />
<cause idref="T46" />
<clue>Preincubation of cells with 1,25-(OH)2D3 had no effect on the time course of IL-1 beta mRNA appearance <linkCause>in response to</linkCause> LPS.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E28">
<type class="Regulation" />
<theme idref="E27" />
<cause idref="E25" />
<clue>Preincubation of cells with 1,25-(OH)2D3 had no <clueType>effect</clueType> <linkTheme>on</linkTheme> the time course of IL-1 beta mRNA appearance in response to LPS.</clue>
</event>
<sentence id="S9">However, exposure of <term sem="Cell_cultured" id="T47" lex="U-937_cell">U-937 cells</term> to <term sem="Lipid" id="T48" lex="1,25-(OH)2D3">1,25-(OH)2D3</term> increased by 200% the level of <term sem="RNA_molecule" id="T49" lex="IL-1_beta_mRNA"><term sem="Protein_molecule" id="T50" lex="IL-1_beta">IL-1 beta</term> mRNA</term> detected and decreased by three orders of magnitude the concentration of <term sem="Lipid" id="T51" lex="LPS">LPS</term> required to achieve steady state <term sem="Other" id="T52" lex="mRNA_level">mRNA levels</term> equivalent to those observed in <term sem="Cell_cultured" id="T53" lex="U-937_cell">U-937 cells</term> not preincubated with the hormone.2+o</sentence>
<event id="E29">
<type class="Physiological_process" />
<theme idref="T47" />
<cause idref="T48" />
<clue>However, <clueType>exposure</clueType> <linkTheme>of</linkTheme> U-937 cells <linkCause>to</linkCause> 1,25-(OH)2D3 increased by 200% the level of IL-1 beta mRNA detected and decreased by three orders of magnitude the concentration of LPS required to achieve steady state mRNA levels equivalent to those observed in U-937 cells not preincubated with the hormone.2+o</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T49" />
<cause idref="E29" />
<clue>However, exposure of U-937 cells to 1,25-(OH)2D3 <clueType>increased</clueType> by 200% the level of IL-1 beta mRNA detected and decreased by three orders of magnitude the concentration of LPS required to achieve steady state mRNA levels equivalent to those observed in U-937 cells not preincubated with the hormone.2+o</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
